Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C.

Schnell D, Deruddre S, Harrois A, Pottecher J, Cosson C, Adoui N, Benhamou D, Vicaut E, Azoulay E, Duranteau J.

Shock. 2012 Dec;38(6):592-7. doi: 10.1097/SHK.0b013e318271a39c.

PMID:
23042202
2.

Subtle change of cystatin C, with or without acute kidney injury, associated with increased mortality in the intensive care unit.

Kwon SH, Hyun J, Jeon JS, Noh H, Han DC.

J Crit Care. 2011 Dec;26(6):566-71. doi: 10.1016/j.jcrc.2011.01.004.

PMID:
21419594
3.

A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury.

Bagshaw SM, Haase M, Haase-Fielitz A, Bennett M, Devarajan P, Bellomo R.

Nephrol Dial Transplant. 2012 Feb;27(2):582-8. doi: 10.1093/ndt/gfr331.

4.

[Value of creatinine clearance rate estimated based on serum cystatin C in patients with acute kidney injury].

Hu JT, Xie XL, Tang ZH, Li CQ, Zhou HW.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Sep;24(9):534-7. Chinese.

5.

Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients.

Mårtensson J, Martling CR, Oldner A, Bell M.

Nephrol Dial Transplant. 2012 Feb;27(2):576-81. doi: 10.1093/ndt/gfr358.

6.

Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit.

Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM, Frampton CM, Endre ZH.

Crit Care. 2010;14(3):R85. doi: 10.1186/cc9014.

7.

Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients.

Mazul-Sunko B, Zarković N, Vrkić N, Antoljak N, Bekavac Beslin M, Nikolić Heitzler V, Siranović M, Krizmanić-Dekanić A, Klinger R.

Nephron Clin Pract. 2004;97(3):c103-7.

PMID:
15292687
8.

Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT).

Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, Rocco M, Alessandri E, Giunta F, Michetti V, Iannuzzi M, Belluomo Anello C, Brienza N, Carlini M, Pelaia P, Gabbanelli V, Ronco C; NEFROINT Investigators..

Minerva Anestesiol. 2011 Nov;77(11):1072-83.

9.

Urinary cystatin C levels as a diagnostic and prognostic biomarker in patients with acute kidney injury.

Park MY, Choi SJ, Kim JK, Hwang SD, Lee YW.

Nephrology (Carlton). 2013 Apr;18(4):256-62. doi: 10.1111/nep.12037.

PMID:
23414098
10.

RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit.

Garzotto F, Piccinni P, Cruz D, Gramaticopolo S, Dal Santo M, Aneloni G, Kim JC, Rocco M, Alessandri E, Giunta F, Michetti V, Iannuzzi M, Belluomo Anello C, Brienza N, Carlini M, Pelaia P, Gabbanelli V, Ronco C; NEFROINT investigation group..

Blood Purif. 2011;31(1-3):159-71. doi: 10.1159/000322161.

11.
12.

Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?

Gaygısız Ü, Aydoğdu M, Badoğlu M, Boyacı N, Güllü Z, Gürsel G.

Scand J Clin Lab Invest. 2016;76(2):143-50. doi: 10.3109/00365513.2015.1126854.

PMID:
26767714
13.
14.

Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury.

Chou YH, Huang TM, Wu VC, Wang CY, Shiao CC, Lai CF, Tsai HB, Chao CT, Young GH, Wang WJ, Kao TW, Lin SL, Han YY, Chou A, Lin TH, Yang YW, Chen YM, Tsai PR, Lin YF, Huang JW, Chiang WC, Chou NK, Ko WJ, Wu KD, Tsai TJ; NSARF Study Group..

Crit Care. 2011;15(3):R134. doi: 10.1186/cc10252.

15.

Analysis of progression in risk, injury, failure, loss, and end-stage renal disease classification on outcome in patients with severe sepsis and septic shock.

Kim WY, Huh JW, Lim CM, Koh Y, Hong SB.

J Crit Care. 2012 Feb;27(1):104.e1-7. doi: 10.1016/j.jcrc.2011.04.005.

PMID:
21715135
16.

Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes.

Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators..

Clin J Am Soc Nephrol. 2007 May;2(3):431-9.

17.

Severe post-renal acute kidney injury, post-obstructive diuresis and renal recovery.

Hamdi A, Hajage D, Van Glabeke E, Belenfant X, Vincent F, Gonzalez F, Ciroldi M, Obadia E, Chelha R, Pallot JL, Das V.

BJU Int. 2012 Dec;110(11 Pt C):E1027-34. doi: 10.1111/j.1464-410X.2012.11193.x.

18.

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.

Royakkers AA, Korevaar JC, van Suijlen JD, Hofstra LS, Kuiper MA, Spronk PE, Schultz MJ, Bouman CS.

Intensive Care Med. 2011 Mar;37(3):493-501. doi: 10.1007/s00134-010-2087-y.

19.

Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults.

Haase M, Bellomo R, Devarajan P, Ma Q, Bennett MR, Möckel M, Matalanis G, Dragun D, Haase-Fielitz A.

Ann Thorac Surg. 2009 Jul;88(1):124-30. doi: 10.1016/j.athoracsur.2009.04.023.

PMID:
19559209
20.
Items per page

Supplemental Content

Support Center